NCT03976531

Brief Summary

Older adults with cancer remain underrepresented in cancer clinical trials that establish new standards of care. Geriatric assessment (GA) is defined by geriatricians as a multidimensional interdisciplinary assessment of the general health stat us of the older patient, reviewing the medical, psychosocial, functional and environmental domains. For each domain, several tools are available, but consensus is lacking on which tool to use and the optimal cut-offs or threshold scores. The literature supports the prognostic value of the GA and its utility in weighing the benefits and risks of cancer treatments in older adults. However, GA has not been implemented in routine oncology practice or in cancer clinical trials. The objective of this project is to develop a set of geriatric data, the Geriatric Core Dataset (G-CODE), to be collected in cancer trials of older patients. The methods rely on a consensus process involving international experts in the field of oncology and geriatrics.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
42

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jan 2015

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2015

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2017

Completed
2.4 years until next milestone

First Submitted

Initial submission to the registry

May 23, 2019

Completed
14 days until next milestone

First Posted

Study publicly available on registry

June 6, 2019

Completed
1.6 years until next milestone

Results Posted

Study results publicly available

January 20, 2021

Completed
Last Updated

January 20, 2021

Status Verified

December 1, 2020

Enrollment Period

2 years

First QC Date

May 23, 2019

Results QC Date

November 25, 2020

Last Update Submit

December 30, 2020

Conditions

Keywords

cancerelderlyrandomized trialconsensus

Outcome Measures

Primary Outcomes (8)

  • Number of Experts Who Considered That the Question "Do You Live Alone ?" Should be Retained in the G-CODE

    Day 1

  • Number of Experts Who Considered That the Question "do You Have a Person or Caregiver Able to Provide Care and Support" Should be Retained in the G-CODE

    Day 1

  • Number of Experts Who Considered That the Tool "ADL (Activities of Daily Living)" Should be Retained in the G-CODE

    Day 1

  • Number of Experts Who Considered That the Tool "4-IADL (Instrumental Activities of Daily Living)" Should be Retained in the G-CODE

    Day 1

  • Number of Experts Who Considered That the Test "Timed Up and Go" Should be Retained in the G-CODE

    Day 1

  • Number of Experts Who Considered That the Items "Weight Loss During the Past 6 Months and Body Mass Index (BMI)" Should be Retained in the G-CODE

    Day 1

  • Number of Experts Who Considered That the Item "One Cognitive Scale (Mini-Cog)" Should be Retained in the G-CODE

    Day 1

  • Number of Experts Who Considered That the Item "Char Lson Comorbidity Index" Should be Retained in the G-CODE

    Day 1

Study Arms (1)

Elderly cancer patients included in randomized controlled trials

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The panel of experts (cancer specialists, clinical research associates, nurses) was in charge of assessing the the relevance and approppriateness of the selected tools to include in the Geriatric Core Data Set (G-Code).

* cancer specialists (medical oncologists, surgeons, radiation oncologists, geriatricians, disease-oriented oncologists, clinical oncologists) * clinical research associates * nurses.

Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.

Sponsors & Collaborators

Study Sites (1)

Institut Bergonié, Comprehensive Cancer Center

Bordeaux, France

Location

Related Publications (1)

  • Paillaud E, Soubeyran P, Caillet P, Cudennec T, Brain E, Terret C, Etchepare F, Mourey L, Aparicio T, Pamoukdjian F, Audisio RA, Rostoft S, Hurria A, Bellera C, Mathoulin-Pelissier S; G-CODE collaborators. Multidisciplinary development of the Geriatric Core Dataset for clinical research in older patients with cancer: A French initiative with international survey. Eur J Cancer. 2018 Nov;103:61-68. doi: 10.1016/j.ejca.2018.07.137. Epub 2018 Sep 11.

MeSH Terms

Conditions

Neoplasms

Results Point of Contact

Title
Pr S Mathoulin-Pélissier
Organization
Institut Bergonié

Study Officials

  • Simone Mathoulin-Pélissier, MD/PhD

    Institut Bergonié

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 23, 2019

First Posted

June 6, 2019

Study Start

January 1, 2015

Primary Completion

January 1, 2017

Study Completion

January 1, 2017

Last Updated

January 20, 2021

Results First Posted

January 20, 2021

Record last verified: 2020-12

Locations